Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age
Identifieur interne : 000654 ( Istex/Checkpoint ); précédent : 000653; suivant : 000655Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age
Auteurs : A. I. Klimov [États-Unis] ; I. V. Kiseleva [Russie] ; J. A. Desheva [Russie] ; G. I. Alexandrova [Russie] ; N. J. Cox [États-Unis] ; L. G. Rudenko [Russie]Source :
- International congress series [ 0531-5131 ] ; 2001.
English descriptors
- Teeft :
Abstract
Abstract: Background: Live influenza A vaccines (LIVs) for adults and children are prepared in Russia by reassorting current epidemic strains with cold-adapted (ca) attenuated donor viruses A/Leningrad/134/17/57 (H2N2) (Len/17) and A/Leningrad/134/47/57 (H2N2) (Len/47), respectively. Len/17 and Len/47 were derived from the A/Leningrad/134/57 (H2N2) wild-type virus after 17 and 47 passages in eggs at 25 °C. Two doses of Len/47-based vaccine have been used for vaccinating children. In a recent study, children were vaccinated with the Len/17-based LIV in order to determine if this vaccine is safe and immunogenic after a single dose vaccination. As part of this study, type A isolates obtained from children 3–6 years of age on the third day after vaccination were analyzed for genetic stability. Methods: PCR-restriction (RFLP) analysis was used to detect mutations in genomes of isolates. Results: Internal genes of Len/17 contain eight coding mutations in the PB2 (1), PB1 (2), PA (2), M1 (1), M2 (1) and NS (1) genes. All of these mutations, except one, were conserved in the genomes of all 28 strains studied. Similar to other studies with Len/17, the A-86-T change in the M2 protein, which was shown to be heterogeneous in the parent donor strain, was absent in 13 isolates. Since it was shown that mutations in polymerase genes play a leading role in the attenuation of Len/17, it is important to emphasize their conservation in all of the isolates. Moreover, an additional mutation in the PB2 protein (S-478-R), previously known only for the more attenuated Len/47 ca donor strain, was detected in 9 of 28 isolates, indicating that this mutation may also be heterogeneous in the donor virus. Conclusion: The Len/17-based LIV is genetically stable in children.
Url:
DOI: 10.1016/S0531-5131(01)00020-6
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:3C35F12C425DB52E73CF2BBCBAFA9416C1FB67A7Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age</title><author><name sortKey="Klimov, A I" sort="Klimov, A I" uniqKey="Klimov A" first="A. I." last="Klimov">A. I. Klimov</name></author><author><name sortKey="Kiseleva, I V" sort="Kiseleva, I V" uniqKey="Kiseleva I" first="I. V." last="Kiseleva">I. V. Kiseleva</name></author><author><name sortKey="Desheva, J A" sort="Desheva, J A" uniqKey="Desheva J" first="J. A." last="Desheva">J. A. Desheva</name></author><author><name sortKey="Alexandrova, G I" sort="Alexandrova, G I" uniqKey="Alexandrova G" first="G. I." last="Alexandrova">G. I. Alexandrova</name></author><author><name sortKey="Cox, N J" sort="Cox, N J" uniqKey="Cox N" first="N. J." last="Cox">N. J. Cox</name></author><author><name sortKey="Rudenko, L G" sort="Rudenko, L G" uniqKey="Rudenko L" first="L. G." last="Rudenko">L. G. Rudenko</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3C35F12C425DB52E73CF2BBCBAFA9416C1FB67A7</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1016/S0531-5131(01)00020-6</idno><idno type="url">https://api.istex.fr/ark:/67375/6H6-GFVF3PWB-7/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000034</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000034</idno><idno type="wicri:Area/Istex/Curation">000034</idno><idno type="wicri:Area/Istex/Checkpoint">000654</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000654</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age</title><author><name sortKey="Klimov, A I" sort="Klimov, A I" uniqKey="Klimov A" first="A. I." last="Klimov">A. I. Klimov</name><affiliation></affiliation><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Branch, G-16, Centers for Disease Control and Prevention, 1600 Clifton Rd., NE, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Kiseleva, I V" sort="Kiseleva, I V" uniqKey="Kiseleva I" first="I. V." last="Kiseleva">I. V. Kiseleva</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Department of Virology, Institute of Experimental Medicine, RAMS, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Desheva, J A" sort="Desheva, J A" uniqKey="Desheva J" first="J. A." last="Desheva">J. A. Desheva</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Department of Virology, Institute of Experimental Medicine, RAMS, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Alexandrova, G I" sort="Alexandrova, G I" uniqKey="Alexandrova G" first="G. I." last="Alexandrova">G. I. Alexandrova</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Department of Virology, Institute of Experimental Medicine, RAMS, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author><author><name sortKey="Cox, N J" sort="Cox, N J" uniqKey="Cox N" first="N. J." last="Cox">N. J. Cox</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Influenza Branch, G-16, Centers for Disease Control and Prevention, 1600 Clifton Rd., NE, Atlanta, GA</wicri:regionArea><placeName><region type="state">Géorgie (États-Unis)</region></placeName></affiliation></author><author><name sortKey="Rudenko, L G" sort="Rudenko, L G" uniqKey="Rudenko L" first="L. G." last="Rudenko">L. G. Rudenko</name><affiliation wicri:level="1"><country xml:lang="fr">Russie</country><wicri:regionArea>Department of Virology, Institute of Experimental Medicine, RAMS, St. Petersburg</wicri:regionArea><wicri:noRegion>St. Petersburg</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">International congress series</title><title level="j" type="abbrev">ICS</title><idno type="ISSN">0531-5131</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2001">2001</date><biblScope unit="volume">1219</biblScope><biblScope unit="supplement">C</biblScope><biblScope unit="page" from="951">951</biblScope><biblScope unit="page" to="954">954</biblScope></imprint><idno type="ISSN">0531-5131</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0531-5131</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Alexandrova</term><term>Attenuated</term><term>Attenuation</term><term>Coding mutations</term><term>Donor strain</term><term>Donor virus</term><term>Elsevier</term><term>Epidemic strains</term><term>Genetic stability</term><term>Genome</term><term>Immunogenic</term><term>Influenza</term><term>Internal genes</term><term>International congress series</term><term>Klimov</term><term>Livs</term><term>More attenuated</term><term>Mutation</term><term>Reassortant</term><term>Vaccinated</term><term>Vaccine</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Background: Live influenza A vaccines (LIVs) for adults and children are prepared in Russia by reassorting current epidemic strains with cold-adapted (ca) attenuated donor viruses A/Leningrad/134/17/57 (H2N2) (Len/17) and A/Leningrad/134/47/57 (H2N2) (Len/47), respectively. Len/17 and Len/47 were derived from the A/Leningrad/134/57 (H2N2) wild-type virus after 17 and 47 passages in eggs at 25 °C. Two doses of Len/47-based vaccine have been used for vaccinating children. In a recent study, children were vaccinated with the Len/17-based LIV in order to determine if this vaccine is safe and immunogenic after a single dose vaccination. As part of this study, type A isolates obtained from children 3–6 years of age on the third day after vaccination were analyzed for genetic stability. Methods: PCR-restriction (RFLP) analysis was used to detect mutations in genomes of isolates. Results: Internal genes of Len/17 contain eight coding mutations in the PB2 (1), PB1 (2), PA (2), M1 (1), M2 (1) and NS (1) genes. All of these mutations, except one, were conserved in the genomes of all 28 strains studied. Similar to other studies with Len/17, the A-86-T change in the M2 protein, which was shown to be heterogeneous in the parent donor strain, was absent in 13 isolates. Since it was shown that mutations in polymerase genes play a leading role in the attenuation of Len/17, it is important to emphasize their conservation in all of the isolates. Moreover, an additional mutation in the PB2 protein (S-478-R), previously known only for the more attenuated Len/47 ca donor strain, was detected in 9 of 28 isolates, indicating that this mutation may also be heterogeneous in the donor virus. Conclusion: The Len/17-based LIV is genetically stable in children.</div></front></TEI><affiliations><list><country><li>Russie</li><li>États-Unis</li></country><region><li>Géorgie (États-Unis)</li></region></list><tree><country name="États-Unis"><region name="Géorgie (États-Unis)"><name sortKey="Klimov, A I" sort="Klimov, A I" uniqKey="Klimov A" first="A. I." last="Klimov">A. I. Klimov</name></region><name sortKey="Cox, N J" sort="Cox, N J" uniqKey="Cox N" first="N. J." last="Cox">N. J. Cox</name></country><country name="Russie"><noRegion><name sortKey="Kiseleva, I V" sort="Kiseleva, I V" uniqKey="Kiseleva I" first="I. V." last="Kiseleva">I. V. Kiseleva</name></noRegion><name sortKey="Alexandrova, G I" sort="Alexandrova, G I" uniqKey="Alexandrova G" first="G. I." last="Alexandrova">G. I. Alexandrova</name><name sortKey="Desheva, J A" sort="Desheva, J A" uniqKey="Desheva J" first="J. A." last="Desheva">J. A. Desheva</name><name sortKey="Rudenko, L G" sort="Rudenko, L G" uniqKey="Rudenko L" first="L. G." last="Rudenko">L. G. Rudenko</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000654 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000654 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Istex
|étape= Checkpoint
|type= RBID
|clé= ISTEX:3C35F12C425DB52E73CF2BBCBAFA9416C1FB67A7
|texte= Live attenuated reassortant influenza vaccine prepared using A/Leningrad/134/17/57 (H2N2) donor strain is genetically stable after replication in children 3-6 years of age
}}
| This area was generated with Dilib version V0.6.33. |  |